GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Odontoprev SA (BSP:ODPV3) » Definitions » EBIT

Odontoprev (BSP:ODPV3) EBIT : R$800 Mil (TTM As of Mar. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Odontoprev EBIT?

Odontoprev's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2024 was R$223 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2024 was R$800 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Odontoprev's annualized ROC % for the quarter that ended in Mar. 2024 was 25.31%. Odontoprev's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 1,670.22%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Odontoprev's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 12.93%.


Odontoprev EBIT Historical Data

The historical data trend for Odontoprev's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Odontoprev EBIT Chart

Odontoprev Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 408.85 523.91 550.16 553.61 760.79

Odontoprev Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 203.88 215.52 189.12 172.98 222.88

Competitive Comparison of Odontoprev's EBIT

For the Healthcare Plans subindustry, Odontoprev's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Odontoprev's EV-to-EBIT Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Odontoprev's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Odontoprev's EV-to-EBIT falls into.



Odontoprev EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was R$800 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odontoprev  (BSP:ODPV3) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Odontoprev's annualized ROC % for the quarter that ended in Mar. 2024 is calculated as:

ROC % (Q: Mar. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Mar. 2024 ))/ count )
=746.948 * ( 1 - 30.44% )/( (2025.175 + 2079.761)/ 2 )
=519.5770288/2052.468
=25.31 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2163.973 - 269.955 - ( 372.024 - max(0, 648.332 - 517.175+372.024))
=2025.175

Invested Capital(Q: Mar. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2329.279 - 307.42 - ( 538.269 - max(0, 709.145 - 651.243+538.269))
=2079.761

Note: The Operating Income data used here is four times the quarterly (Mar. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Odontoprev's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Mar. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Mar. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=891.504/( ( (55.06 + max(-572.885, 0)) + (51.693 + max(-621.717, 0)) )/ 2 )
=891.504/( ( 55.06 + 51.693 )/ 2 )
=891.504/53.3765
=1,670.22 %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(32.912 + 1.423 + 35.466) - (269.955 + 0 + 372.731)
=-572.885

Working Capital(Q: Mar. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(46.16 + 0.001 + 35.813) - (307.42 + 0 + 396.271)
=-621.717

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Odontoprev's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2024 )
=800.494/6190.925
=12.93 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Odontoprev EBIT Related Terms

Thank you for viewing the detailed overview of Odontoprev's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Odontoprev (BSP:ODPV3) Business Description

Traded in Other Exchanges
N/A
Address
Avenida Marcos Penteado de Ulhoa Rodrigues, 939 - 14th Floor, section 1401, Jatoba Building, Castelo Branco Office Park, Tambore, Barueri, SP, BRA, 06460-040
Odontoprev SA provides dental benefit plans throughout Brazil and operates a sizable network of dentists throughout the country. The firm operates in three segments based on client size as well as one auxiliary segment that includes dental care goods and services. The dental care plan segments include corporate plans with many contracts (more than 200); small and midsize, with smaller groups of contracts; and individual, which includes monthly and annual plans sold directly to individuals. The majority of Odontoprev's revenue is generated by the corporate segment.

Odontoprev (BSP:ODPV3) Headlines

No Headlines